Yasuko Imagawa - Concepedia

Concepedia

Author

Yasuko Imagawa

Taisho Pharmaceutical (Japan)

Also Known As

Y Imagawa, Y. Imagawa, Yasuko Imagawa

16

Publications

1.2K

Citations

9

H-Index

32

Concepts

All Affiliations

Taisho Pharmaceutical (Japan)Vanderbilt University

YI

About

Yasuko Imagawa is an author at Taisho Pharmaceutical (Japan) specializing in medicine, neuroscience, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.2K
2	Social Sciences	4	4	192
3	Neurology	2	2	27
4	Health Sciences	1	1	12
5	Immunology	1	1	120

Yasuko Imagawa

×

8

Publications

1.2K

Citations

8

H-Index

	Year	Citations
Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor Toshihiro Ichiki, Patricia A. Labosky, Chiyo Shiota, Nature HypertensionExploratory BehaviourCardiovascular DiseaseMedicineAntihypertensive Therapy	1995	859
NE-100, a novel sigma receptor ligand: In vivo tests Shigeru Okuyama, Yasuko Imagawa, Shinichi Ogawa, Life Sciences Autoimmune DiseaseNovel TherapyMedicineImmunologyTherapeutic Efficacy	1993	120
Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor Shigeru Okuyama, Takashi Sakagawa, Shigeyuki Chaki, Brain Research PsychoneuroimmunologyPsychiatryBehavioral NeuroscienceBehavioural PharmacologyPhysiology	1999	119
NE-100, a novel sigma receptor ligand: Effect on phencyclidine-induced behaviors in rats, dogs and monkeys Shigeru Okuyama, Yasuko Imagawa, Takashi Sakagawa, Life Sciences Phencyclidine-induced BehaviorsBehavioral NeuroscienceMedicineBehavioural PharmacologyBehavioral Pharmacology	1994	39
In Vitro and In Vivo Characterization of the Dopamine D4 Receptor, Serotonin 5-HT2AReceptor and Alpha-1 Adrenoceptor Antagonist (R)-(+)-2-Amino-4-(4-Fluorophenyl)- 5-[1-[4-(4-Fluorophenyl)-4-Oxobutyl]Pyrrolidin-3-yl]Thiazole (NRA0045) Shigeru Okuyama, Shigeyuki Chaki, Ryoko Yoshikawa, Journal of Pharmacology and Experimental Therapeutics	1997	27
Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice S. Okuyama, Yasuko Imagawa, Kazuyuki Tomisawa Neuropharmacology Monoamine-depleted MicePsychiatryBehavioral NeuroscienceMedicinePsychotropic Medication	1996	19
Effect of VA-045 on a closed head injury model in rats Shigeru Okuyama, Yasuko Imagawa, Shin-ichi Ogawa, Life Sciences Cerebral Vascular RegulationTraumatic Brain InjuryNeurophysiologyPhysiologyBrain Injury	1993	15
Effects of VA-045, a novel apovincaminic acid derivative, on age-related impairment evidence in electroencephalograph, caudate spindle, a passive avoidance task and cerebral blood flow in rats Shigeru Okuyama, Sanae Hashimoto-Kitsukawa, Shinichi Ogawa, General Pharmacology The Vascular System NeurophysiologyPhysiologyCaudate SpindleAge-related Impairment EvidenceNeuropharmacology	1994	12

Page 1